Jean-Pierre Devogelaer

发表

Do we have to revise the plasma values of 25OHD in normal elderly subjects

Jean-Pierre Devogelaer, Philippe De Nayer, Jean-Marie Ketelslegers, 2004 .

[Soft-tissue Destruction of Digits in Rheumatic Disorders - a Study of 43 Cases]

Jean-Pierre Devogelaer, Jp. Huaux, Walter Esselinckx, 1987 .

Bone-mineral Density in Addisons-disease

Jean-Pierre Devogelaer, Cn. Dedeuxchaisnes, Jean Crabbé, 1987 .

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Jean-Pierre Devogelaer, Patrick Emonts, René Rizzoli, 2016, Aging Clinical and Experimental Research.

Founder Effect in Different European Countries for the Recurrent P392L SQSTM1 Mutation in Paget’s Disease of Bone

Jean-Pierre Devogelaer, Rene Westhovens, Marcel Karperien, 2008, Calcified Tissue International.

Health Technology Assessment in Osteoporosis

Jean-Pierre Devogelaer, Steven Boonen, Jean-Yves Reginster, 2013, Calcified Tissue International.

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.

Jean-Pierre Devogelaer, Andrea Laslop, Jean-Yves Reginster, 2004, Osteoarthritis and cartilage.

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

Jean-Pierre Devogelaer, Kim Brixen, Jean-Yves Reginster, 2007, The Journal of clinical endocrinology and metabolism.

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

Jean-Pierre Devogelaer, Kenneth G Saag, Richard Eastell, 2009, Arthritis and rheumatism.

Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity.

Jean-Pierre Devogelaer, J. Devogelaer, Daniel-Henri Manicourt, 2004, Arthritis and rheumatism.

Osteogenesis imperfecta and short stature: effect of sclerostin antibody treatment in oim/oim mice

Jean-Pierre Devogelaer, Catherine Nyssen-Behets, Michael S. Ominsky, 2013 .